https://it.marketscreener.com/quotazioni/azione/RECCE-PHARMACEUTICALS-LTD-24446338/attualita/Recce-Pharmaceuticals-completa-il-dosaggio-nello-studio-clinico-di-Fase-I-II-di-Recce-327-per-le-i-44942624/?utm_source=telegram&utm_medium=social&utm_campaign=share